Skip to main content
. 2021 Nov 15;13(11):1551–1560. doi: 10.4251/wjgo.v13.i11.1551

Figure 1.

Figure 1

Main resistance mechanisms in targeted treatment for metastatic colorectal cancer. EGFR: Epidermal growth factor receptor; VEGF: Vascular endothelial growth factor; TGF-β: Transforming growth factor-β; IL1: Interleukin 1.